FibroBiologics Inc. (FBLG)
(Delayed Data from NSDQ)
$10.75 USD
-0.25 (-2.27%)
Updated May 22, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
FBLG 10.75 -0.25(-2.27%)
Will FBLG be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for FBLG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for FBLG
FBLG Stock Earnings: FibroBiologics, Inc. – Common Stock Reported Results for Q1 2024
FibroBiologics GAAP EPS of -$0.27
FibroBiologics files to sell 1.8M units on a best efforts basis
FibroBiologics files to sell 1.8M units
FibroBiologics plans to collaborate with Charles River